Utama › Kolitis Ulseratif › Colorado › Colorado Springs
Kajian klinikal Kolitis Ulseratif di Colorado Springs, CO
14 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi dalam dan sekitar Colorado Springs (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Mengambil pesertaFasa 4
- Peak Gastroenterology Associates, Colorado Springs
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates, Colorado Springs
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Mengambil pesertaFasa 2
- Site 033, Colorado Springs
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates ( Site 1052), Colorado Springs
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates, Colorado Springs
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates, Colorado Springs
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
- Peak Gastroenterology Associates, Colorado Springs
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Mengambil pesertaFasa 2
- Peak Gastroenterology Associates, Colorado Springs
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mengambil pesertaFasa 2
- Mirador Therapeutics Selected Site, Colorado Springs
Kajian Kolitis Ulseratif di bandar lain
- New York City, NY23 kajian
- Orlando, FL22 kajian
- Miami, FL21 kajian
- Houston, TX17 kajian
- San Antonio, TX16 kajian
- Chicago, IL15 kajian
- Tacoma, WA15 kajian
- San Diego, CA15 kajian
- Tyler, TX14 kajian
- Los Angeles, CA13 kajian
- St. Louis, MO13 kajian
- Washington, DC12 kajian
Kajian lain di Colorado Springs
- Penyakit Crohn13 kajian
- Kanser Prostat12 kajian
- Kanser Paru-paru Bukan Sel Kecil11 kajian
- Kanser Paru-paru8 kajian
- Kanser Payudara7 kajian
- Asma6 kajian
- Kanser Kolorektal6 kajian
- Kanser Kolon6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher4 kajian
- Melanoma4 kajian
- Kanser Rektum4 kajian
- Penyakit Usus Radang4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.